Logo image of RRX

REGAL REXNORD CORP (RRX) Stock Fundamental Analysis

NYSE:RRX - New York Stock Exchange, Inc. - US7587501039 - Common Stock

156.5  -1.96 (-1.24%)

After market: 156.11 -0.39 (-0.25%)

Fundamental Rating

5

Taking everything into account, RRX scores 5 out of 10 in our fundamental rating. RRX was compared to 93 industry peers in the Electrical Equipment industry. Both the profitability and the financial health of RRX get a neutral evaluation. Nothing too spectacular is happening here. RRX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year RRX was profitable.
In the past year RRX had a positive cash flow from operations.
RRX had positive earnings in 4 of the past 5 years.
In the past 5 years RRX always reported a positive cash flow from operatings.
RRX Yearly Net Income VS EBIT VS OCF VS FCFRRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

1.2 Ratios

The Return On Assets of RRX (1.45%) is better than 73.63% of its industry peers.
RRX's Return On Equity of 3.26% is fine compared to the rest of the industry. RRX outperforms 72.53% of its industry peers.
RRX's Return On Invested Capital of 4.45% is fine compared to the rest of the industry. RRX outperforms 71.43% of its industry peers.
RRX had an Average Return On Invested Capital over the past 3 years of 4.62%. This is significantly below the industry average of 10.46%.
Industry RankSector Rank
ROA 1.45%
ROE 3.26%
ROIC 4.45%
ROA(3y)2.2%
ROA(5y)3.22%
ROE(3y)3.45%
ROE(5y)5.59%
ROIC(3y)4.62%
ROIC(5y)5.56%
RRX Yearly ROA, ROE, ROICRRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 2 4 6 8 10

1.3 Margins

RRX has a better Profit Margin (3.41%) than 75.82% of its industry peers.
Looking at the Operating Margin, with a value of 11.91%, RRX belongs to the top of the industry, outperforming 82.42% of the companies in the same industry.
RRX's Operating Margin has been stable in the last couple of years.
RRX's Gross Margin of 36.89% is amongst the best of the industry. RRX outperforms 85.71% of its industry peers.
RRX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.91%
PM (TTM) 3.41%
GM 36.89%
OM growth 3Y-0.72%
OM growth 5Y0.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.92%
GM growth 5Y4.95%
RRX Yearly Profit, Operating, Gross MarginsRRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30

4

2. Health

2.1 Basic Checks

RRX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
RRX has about the same amout of shares outstanding than it did 1 year ago.
RRX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, RRX has a worse debt to assets ratio.
RRX Yearly Shares OutstandingRRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
RRX Yearly Total Debt VS Total AssetsRRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

RRX has an Altman-Z score of 1.71. This is a bad value and indicates that RRX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of RRX (1.71) is comparable to the rest of the industry.
The Debt to FCF ratio of RRX is 11.62, which is on the high side as it means it would take RRX, 11.62 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 11.62, RRX is in the better half of the industry, outperforming 67.03% of the companies in the same industry.
RRX has a Debt/Equity ratio of 0.87. This is a neutral value indicating RRX is somewhat dependend on debt financing.
RRX has a Debt to Equity ratio of 0.87. This is in the lower half of the industry: RRX underperforms 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 11.62
Altman-Z 1.71
ROIC/WACC0.42
WACC10.71%
RRX Yearly LT Debt VS Equity VS FCFRRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.3 Liquidity

RRX has a Current Ratio of 2.45. This indicates that RRX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of RRX (2.45) is better than 68.13% of its industry peers.
RRX has a Quick Ratio of 1.35. This is a normal value and indicates that RRX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of RRX (1.35) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.45
Quick Ratio 1.35
RRX Yearly Current Assets VS Current LiabilitesRRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

4

3. Growth

3.1 Past

The earnings per share for RRX have decreased by -4.83% in the last year.
RRX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.76% yearly.
Looking at the last year, RRX shows a small growth in Revenue. The Revenue has grown by 4.99% in the last year.
RRX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.39% yearly.
EPS 1Y (TTM)-4.83%
EPS 3Y16.66%
EPS 5Y8.76%
EPS Q2Q%18.57%
Revenue 1Y (TTM)4.99%
Revenue growth 3Y29.07%
Revenue growth 5Y11.39%
Sales Q2Q%-10.45%

3.2 Future

Based on estimates for the next years, RRX will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.06% on average per year.
RRX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.05% yearly.
EPS Next Y1.98%
EPS Next 2Y7.65%
EPS Next 3Y9.06%
EPS Next 5YN/A
Revenue Next Year-3.24%
Revenue Next 2Y-1.83%
Revenue Next 3Y0.05%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
RRX Yearly Revenue VS EstimatesRRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B
RRX Yearly EPS VS EstimatesRRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.27, RRX is valued on the expensive side.
RRX's Price/Earnings ratio is rather cheap when compared to the industry. RRX is cheaper than 84.62% of the companies in the same industry.
When comparing the Price/Earnings ratio of RRX to the average of the S&P500 Index (27.96), we can say RRX is valued slightly cheaper.
RRX is valuated correctly with a Price/Forward Earnings ratio of 14.74.
Based on the Price/Forward Earnings ratio, RRX is valued cheaply inside the industry as 83.52% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.11, RRX is valued a bit cheaper.
Industry RankSector Rank
PE 17.27
Fwd PE 14.74
RRX Price Earnings VS Forward Price EarningsRRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

RRX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. RRX is cheaper than 82.42% of the companies in the same industry.
81.32% of the companies in the same industry are more expensive than RRX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 21.29
EV/EBITDA 12.49
RRX Per share dataRRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
RRX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)8.72
PEG (5Y)1.97
EPS Next 2Y7.65%
EPS Next 3Y9.06%

5

5. Dividend

5.1 Amount

RRX has a yearly dividend return of 0.88%, which is pretty low.
RRX's Dividend Yield is rather good when compared to the industry average which is at 3.39. RRX pays more dividend than 84.62% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.29, RRX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.88%

5.2 History

The dividend of RRX has a limited annual growth rate of 5.45%.
RRX has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of RRX decreased in the last 3 years.
Dividend Growth(5Y)5.45%
Div Incr Years1
Div Non Decr Years2
RRX Yearly Dividends per shareRRX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

5.3 Sustainability

44.14% of the earnings are spent on dividend by RRX. This is a bit on the high side, but may be sustainable.
The dividend of RRX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP44.14%
EPS Next 2Y7.65%
EPS Next 3Y9.06%
RRX Yearly Income VS Free CF VS DividendRRX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M
RRX Dividend Payout.RRX Dividend Payout, showing the Payout Ratio.RRX Dividend Payout.PayoutRetained Earnings

REGAL REXNORD CORP

NYSE:RRX (1/17/2025, 8:25:16 PM)

After market: 156.11 -0.39 (-0.25%)

156.5

-1.96 (-1.24%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners102.09%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner Change2.58%
Market Cap10.36B
Analysts85.33
Price Target211.75 (35.3%)
Short Float %2.23%
Short Ratio2.99
Dividend
Industry RankSector Rank
Dividend Yield 0.88%
Yearly Dividend1.4
Dividend Growth(5Y)5.45%
DP44.14%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.95%
Min EPS beat(2)-0.43%
Max EPS beat(2)6.33%
EPS beat(4)2
Avg EPS beat(4)1.52%
Min EPS beat(4)-0.54%
Max EPS beat(4)6.33%
EPS beat(8)5
Avg EPS beat(8)0.77%
EPS beat(12)8
Avg EPS beat(12)1.51%
EPS beat(16)11
Avg EPS beat(16)3.27%
Revenue beat(2)1
Avg Revenue beat(2)-1.73%
Min Revenue beat(2)-3.82%
Max Revenue beat(2)0.36%
Revenue beat(4)1
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-3.82%
Max Revenue beat(4)0.36%
Revenue beat(8)1
Avg Revenue beat(8)-2.01%
Revenue beat(12)4
Avg Revenue beat(12)-1.06%
Revenue beat(16)7
Avg Revenue beat(16)0%
PT rev (1m)2.43%
PT rev (3m)5.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.19%
EPS NY rev (1m)-0.22%
EPS NY rev (3m)-2.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.75%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-1.4%
Valuation
Industry RankSector Rank
PE 17.27
Fwd PE 14.74
P/S 1.68
P/FCF 21.29
P/OCF 17.35
P/B 1.6
P/tB N/A
EV/EBITDA 12.49
EPS(TTM)9.06
EY5.79%
EPS(NY)10.62
Fwd EY6.78%
FCF(TTM)7.35
FCFY4.7%
OCF(TTM)9.02
OCFY5.76%
SpS93.32
BVpS97.74
TBVpS-59.02
PEG (NY)8.72
PEG (5Y)1.97
Profitability
Industry RankSector Rank
ROA 1.45%
ROE 3.26%
ROCE 5.51%
ROIC 4.45%
ROICexc 4.6%
ROICexgc 23.65%
OM 11.91%
PM (TTM) 3.41%
GM 36.89%
FCFM 7.88%
ROA(3y)2.2%
ROA(5y)3.22%
ROE(3y)3.45%
ROE(5y)5.59%
ROIC(3y)4.62%
ROIC(5y)5.56%
ROICexc(3y)4.94%
ROICexc(5y)6.15%
ROICexgc(3y)20%
ROICexgc(5y)20.41%
ROCE(3y)5.74%
ROCE(5y)6.89%
ROICexcg growth 3Y-6.98%
ROICexcg growth 5Y-0.95%
ROICexc growth 3Y-21.13%
ROICexc growth 5Y-13.48%
OM growth 3Y-0.72%
OM growth 5Y0.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.92%
GM growth 5Y4.95%
F-Score8
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 11.62
Debt/EBITDA 4.5
Cap/Depr 21.23%
Cap/Sales 1.79%
Interest Coverage 1.86
Cash Conversion 47.53%
Profit Quality 230.87%
Current Ratio 2.45
Quick Ratio 1.35
Altman-Z 1.71
F-Score8
WACC10.71%
ROIC/WACC0.42
Cap/Depr(3y)27.79%
Cap/Depr(5y)37.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.83%
EPS 3Y16.66%
EPS 5Y8.76%
EPS Q2Q%18.57%
EPS Next Y1.98%
EPS Next 2Y7.65%
EPS Next 3Y9.06%
EPS Next 5YN/A
Revenue 1Y (TTM)4.99%
Revenue growth 3Y29.07%
Revenue growth 5Y11.39%
Sales Q2Q%-10.45%
Revenue Next Year-3.24%
Revenue Next 2Y-1.83%
Revenue Next 3Y0.05%
Revenue Next 5YN/A
EBIT growth 1Y12.78%
EBIT growth 3Y28.14%
EBIT growth 5Y12.22%
EBIT Next Year75.68%
EBIT Next 3Y26.64%
EBIT Next 5YN/A
FCF growth 1Y83.05%
FCF growth 3Y15.4%
FCF growth 5Y15.9%
OCF growth 1Y76.98%
OCF growth 3Y18%
OCF growth 5Y14.55%